CVS Health has sold its Omnicare long-term care pharmacy network to GenieRx for $250 million, following approval from a bankruptcy court. The sale is part of CVS's strategy to concentrate on more profitable areas after Omnicare underperformed and faced costly fraud investigations. GenieRx, a partnership between Milrose Capital and Integro Healthcare Services, aims to strengthen Omnicare's services. The deal is expected to close later this year, marking a shift in CVS's portfolio towards reliable and clinically appropriate pharmacy services.
Aetna's latest survey shows U.S. healthcare providers' trust in payers increased to a score of 6.1 from 5.4, reflecting improved perceptions of payer reliability and communication. Providers highlight technology's role in reducing administrative task...
CVS Caremark announced a global settlement with the Federal Trade Commission (FTC) resolving all litigation related to rebate practices, pharmacy network contracting, and vertical integration. The agreement ends ongoing investigations and allows CVS ...
